WINDLAS BIOTECH
Back to Balance Sheet
|
WINDLAS BIOTECH Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹306 Cr | ₹276 Cr | ₹260 Cr | ₹232 Cr | ₹288 Cr |
What is the latest Net Current Assets ratio of WINDLAS BIOTECH ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹306 Cr |
| Mar2025 | ₹276 Cr |
| Mar2024 | ₹260 Cr |
| Mar2023 | ₹232 Cr |
| Mar2022 | ₹288 Cr |
How is Net Current Assets of WINDLAS BIOTECH Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹306 Cr | 10.85 | |
| Mar2025 | ₹276 Cr | 6.34 | |
| Mar2024 | ₹260 Cr | 11.73 | |
| Mar2023 | ₹232 Cr | -19.25 | |
| Mar2022 | ₹288 Cr | - | |
Compare Net Current Assets of peers of WINDLAS BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WINDLAS BIOTECH | ₹1,980.6 Cr | -1.6% | 7% | 18.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,299.0 Cr | 1% | 7.5% | 7.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹297,325.0 Cr | 0.8% | 22.8% | 71.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹178,727.0 Cr | 0.2% | 1.9% | 20.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,145.0 Cr | 0.8% | 12.2% | 12.3% | Stock Analytics | |
| CIPLA | ₹114,312.0 Cr | 1.5% | 6.4% | -7.8% | Stock Analytics | |
WINDLAS BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WINDLAS BIOTECH | -1.6% |
7% |
18.4% |
| SENSEX | 2.9% |
13.9% |
-0.8% |
You may also like the below Video Courses